These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25018574)

  • 1. Estimating Risk with Time-to-Event Data: An Application to the Women's Health Initiative.
    Liu D; Zheng Y; Prentice RL; Hsu L
    J Am Stat Assoc; 2014 Jun; 109(506):514-524. PubMed ID: 25018574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Projection for Time-to-event Outcome Leveraging Summary Statistics With Source Individual-level Data.
    Zheng J; Zheng Y; Hsu L
    J Am Stat Assoc; 2022; 117(540):2043-2055. PubMed ID: 36687294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Goodness-of-fit two-phase sampling designs for time-to-event outcomes: a simulation study based on New York University Women's Health Study for breast cancer.
    Lee M; Chen J; Zeleniuch-Jacquotte A; Liu M
    BMC Med Res Methodol; 2023 May; 23(1):119. PubMed ID: 37208600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk projection for time-to-event outcome from population-based case-control studies leveraging summary statistics from the target population.
    Zheng J; Hsu L
    Lifetime Data Anal; 2024 Jul; 30(3):549-571. PubMed ID: 38805095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More efficient estimators for case-cohort studies.
    Kim S; Cai J; Lu W
    Biometrika; 2013; 100(3):695-708. PubMed ID: 24634519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pseudo-likelihood method for estimating misclassification probabilities in competing-risks settings when true-event data are partially observed.
    Mpofu PB; Bakoyannis G; Yiannoutsos CT; Mwangi AW; Mburu M
    Biom J; 2020 Nov; 62(7):1747-1768. PubMed ID: 32520411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women.
    Matsuno RK; Costantino JP; Ziegler RG; Anderson GL; Li H; Pee D; Gail MH
    J Natl Cancer Inst; 2011 Jun; 103(12):951-61. PubMed ID: 21562243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projecting individualized absolute invasive breast cancer risk in African American women.
    Gail MH; Costantino JP; Pee D; Bondy M; Newman L; Selvan M; Anderson GL; Malone KE; Marchbanks PA; McCaskill-Stevens W; Norman SA; Simon MS; Spirtas R; Ursin G; Bernstein L
    J Natl Cancer Inst; 2007 Dec; 99(23):1782-92. PubMed ID: 18042936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous Individual Risk Modeling of Recurrent Events.
    Ma H; Peng L; Huang CY; Fu H
    Biometrika; 2021 Mar; 108(1):183-198. PubMed ID: 33840817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.
    Crandall CJ; Hovey KM; Andrews CA; Chlebowski RT; Stefanick ML; Lane DS; Shifren J; Chen C; Kaunitz AM; Cauley JA; Manson JE
    Menopause; 2018 Jan; 25(1):11-20. PubMed ID: 28816933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On Estimation of the Hazard Function from Population-based Case-Control Studies.
    Hsu L; Gorfine M; Zucker DM
    J Am Stat Assoc; 2018; 113(522):560-570. PubMed ID: 30906082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive subdistribution hazards regression for competing risks data in case-cohort studies.
    Wogu AF; Li H; Zhao S; Nichols HB; Cai J
    Biometrics; 2023 Dec; 79(4):3010-3022. PubMed ID: 36606409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust best linear estimator for Cox regression with instrumental variables in whole cohort and surrogates with additive measurement error in calibration sample.
    Wang CY; Song X
    Biom J; 2016 Nov; 58(6):1465-1484. PubMed ID: 27546625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
    Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Kooperberg C; Stefanick ML; Jackson RD; Beresford SA; Howard BV; Johnson KC; Kotchen JM; Ockene J;
    JAMA; 2002 Jul; 288(3):321-33. PubMed ID: 12117397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chocolate Candy and Incident Invasive Cancer Risk in the Women's Health Initiative: An Observational Prospective Analysis.
    Greenberg JA; Neuhouser ML; Tinker LF; Lane DS; Paskett ED; Van Horn LV; Wassertheil-Smoller S; Shikany JM; Qi L; Sealy-Jefferson S; Manson JE
    J Acad Nutr Diet; 2021 Feb; 121(2):314-326.e4. PubMed ID: 32763064
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.